DISARM EU

DISARM is an EU-funded Cancer Mission project focused on improving hereditary ovarian cancer (OC) risk assessment and early detection across Europe. It tackles two key gaps: limited access to personalised, accurate risk assessment, and the absence of reliable, accessible tools for early OC detection.

The project will validate several affordable, minimally invasive diagnostic technologies and deploy intelligent digital assets to empower healthcare providers, patients, and policymakers. By combining clinical studies, digital innovation, and participatory stakeholder engagement, DISARM aims to support the adoption of its solutions into routine care across multiple countries.

Co-funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the Health and Digital Executive Agency. Neither the European Union nor the granting authority can be held responsible for them.